When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Daratumumab - Wikipedia

   en.wikipedia.org/wiki/Daratumumab

   Daratumumab was given priority review status by the US Food and Drug Administration (FDA) for multiple myeloma as a combination therapy (second line). [24] Daratumumab phase III trials for multiple myeloma show great promise in combination therapy with lenalidomide and dexamethasone, [32] as well as with bortezomib and dexamethasone. [33 ...

3. Daratumumab/hyaluronidase - Wikipedia

   en.wikipedia.org/wiki/Daratumumab/hyaluronidase

   It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]

4. Genmab’s Darzalex Gets FDA Approval For Blood ... - AOL

   www.aol.com/news/genmab-darzalex-gets-fda...

   Genmab A/S announced on Jan. 15 that its drug, Darzalex Faspro has been approved by the US Food and Drug Administration (FDA) for the treatment of light-chain (AL) amyloidosis in adult patients ...

5. Genmab - Wikipedia

   en.wikipedia.org/wiki/Genmab

   Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. [7] The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan.

6. Sanofi wins US approval for multiple myeloma drug in newly ...

   www.aol.com/news/sanofi-wins-us-approval-drug...

   The drug was given FDA priority review status in May. Sanofi plans to advance blood cancer drugs known as anti-CD38, which include Sarclisa, despite GenMab and Johnson & Johnson's strong foothold ...

7. Amgen (AMGN) Kyprolis Gets FDA Nod for Use With Darzalex Faspro

   www.aol.com/news/amgen-amgn-kyprolis-gets-fda...

   Amgen (AMGN) gets FDA nod for the label expansion of Kyprolis in combination with Darzalex Faspro and dexamethasone for treating patients with multiple myeloma at first or subsequent relapse.